{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:23:15Z","timestamp":1790392995935,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"am","delay-in-days":402,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100014630","name":"France Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","award":["17-EURE-0019"],"award-info":[{"award-number":["17-EURE-0019"]}],"id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","award":["17-EURE-0019"],"award-info":[{"award-number":["17-EURE-0019"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut national de la sant\u00e9 et de la recherche m\u00e9dicale","doi-asserted-by":"publisher","award":["17-EURE-0019"],"award-info":[{"award-number":["17-EURE-0019"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004562","name":"Minist\u00e8re de l'Education Nationale, de l'Enseignement Superieur et de la Recherche","doi-asserted-by":"publisher","award":["17-EURE-0019"],"award-info":[{"award-number":["17-EURE-0019"]}],"id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010102","name":"Institut national de prevention et d'education pour la sante","doi-asserted-by":"publisher","award":["17-EURE-0019"],"award-info":[{"award-number":["17-EURE-0019"]}],"id":[{"id":"10.13039\/100010102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005979","name":"Direction de la recherche des etudes de l'evaluation et des statistiques","doi-asserted-by":"publisher","award":["17-EURE-0019"],"award-info":[{"award-number":["17-EURE-0019"]}],"id":[{"id":"10.13039\/501100005979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007543","name":"ANSM","doi-asserted-by":"publisher","award":["17-EURE-0019"],"award-info":[{"award-number":["17-EURE-0019"]}],"id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.therap.2021.09.001","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T11:15:09Z","timestamp":1631790909000},"page":"349-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["General practitioners\u2019 compliance with benzodiazepine discontinuation guidelines in patients treated with long-term lorazepam: A case-vignette cross-sectional survey"],"prefix":"10.1016","volume":"77","author":[{"given":"Allison","family":"Singier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Verger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2021.09.001_bib0280","series-title":"Clinical practice guidelines: directions for a new program","first-page":"168","author":"Institute of Medicine","year":"1990"},{"key":"10.1016\/j.therap.2021.09.001_bib0285","doi-asserted-by":"crossref","first-page":"e007905","DOI":"10.1136\/bmjopen-2015-007905","article-title":"How GPs value guidelines applied to patients with multimorbidity: A qualitative study","volume":"5","author":"Luijks","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.therap.2021.09.001_bib0290","series-title":"Multimorbidity: technical series on safer primary care","author":"World Health Organization (WHO).","year":"2016"},{"key":"10.1016\/j.therap.2021.09.001_bib0295","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2125.2004.02067.x","article-title":"In defence of polypharmacy","volume":"57","author":"Aronson","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.therap.2021.09.001_bib0300","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/jcm7020017","article-title":"Benzodiazepines I: Upping the care on downers: the evidence of risks, benefits and alternatives","volume":"7","author":"Guina","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.therap.2021.09.001_bib0305","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.therap.2019.03.004","article-title":"Non-drug and drug alternatives to benzodiazepines for insomnia in primary care: Study among GPs and pharmacies in a Southwest region of France","volume":"74","author":"Driot","year":"2019","journal-title":"Therapies"},{"key":"10.1016\/j.therap.2021.09.001_bib0310","article-title":"Training in medical hypnosis and prolonged use of benzodiazepines: The French national health insurance data","author":"L\u00e9gereau","year":"2020","journal-title":"Therapies"},{"key":"10.1016\/j.therap.2021.09.001_bib0315","series-title":"xPharm: The Comprehensive Pharmacology Reference","first-page":"1","article-title":"Lorazepam","author":"Ghiasi","year":"2021"},{"key":"10.1016\/j.therap.2021.09.001_bib0320","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer's disease: case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"issue":"345","key":"10.1016\/j.therap.2021.09.001_bib0325","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study","author":"Billioti de Gage","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2021.09.001_bib0330","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00002512-200825010-00007","article-title":"Benzodiazepines and injurious falls in community dwelling elders","volume":"25","author":"Pariente","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.therap.2021.09.001_bib0335","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bmj.322.7288.704","article-title":"Benzodiazepines and hip fractures in elderly people: Case-control study","volume":"322","author":"Pierfitte","year":"2001","journal-title":"Br Med J"},{"key":"10.1016\/j.therap.2021.09.001_bib0340","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.therap.2018.09.071","article-title":"Benzodiazepines, cognitive decline and dementia: A review of causality criteria from published observational studies","volume":"74","author":"Lapeyre-Mestre","year":"2019","journal-title":"Therapies"},{"key":"10.1016\/j.therap.2021.09.001_bib0345","series-title":"BNF - Hypnotics and anxiolytics, treatment summary","author":"NICE.","year":"2020"},{"key":"10.1016\/j.therap.2021.09.001_bib0350","series-title":"Arr\u00eat des benzodiaz\u00e9pines et m\u00e9dicaments apparent\u00e9s: d\u00e9marche du m\u00e9decin traitant en ambulatoire","author":"Haute autorit\u00e9 de sant\u00e9 (HAS).","year":"2015"},{"key":"10.1016\/j.therap.2021.09.001_bib0355","series-title":"Arr\u00eat\u00e9 du 7 octobre 1991 fixant la liste des substances de la liste I des substances v\u00e9n\u00e9neuses \u00e0 propri\u00e9t\u00e9s hypnotiques et\/ou anxiolytiques dont la dur\u00e9e de prescription est r\u00e9duite","author":"Legifrance","year":"1991"},{"key":"10.1016\/j.therap.2021.09.001_bib0360","series-title":"Loraz\u00e9pam Mylan 1mg, comprim\u00e9 pellicul\u00e9 s\u00e9cable. R\u00e9sum\u00e9 des caract\u00e9ristiques du produit","author":"Base de donn\u00e9es publique des m\u00e9dicaments.","year":"2021"},{"key":"10.1016\/j.therap.2021.09.001_bib0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-018-0966-3","article-title":"Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study","volume":"270","author":"Panes","year":"2020","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.therap.2021.09.001_bib0370","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/pds.4551","article-title":"Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014","volume":"27","author":"Kurko","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2021.09.001_bib0375","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.therap.2021.09.001_bib0380","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.healthpol.2010.03.008","article-title":"Patterns in the use of benzodiazepines in British Columbia: Examining the impact of increasing research and guideline cautions against long-term use","volume":"97","author":"Cunningham","year":"2010","journal-title":"Health Policy"},{"key":"10.1016\/j.therap.2021.09.001_bib0385","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: The process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.therap.2021.09.001_bib0390","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40360-015-0019-8","article-title":"Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: A scoping review","volume":"16","author":"Pollmann","year":"2015","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.therap.2021.09.001_bib0395","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/2042098618804490","article-title":"Deprescribing conversations: a closer look at prescriber-patient communication","volume":"9","author":"Turner","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.therap.2021.09.001_bib0400","series-title":"Benzodiazepine and z-drug withdrawal","author":"NICE.","year":"2020"},{"key":"10.1016\/j.therap.2021.09.001_bib0405","series-title":"\u00c9tat des lieux de la consommation des benzodiaz\u00e9pines en France","author":"ANSM","year":"2017"},{"key":"10.1016\/j.therap.2021.09.001_bib0410","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40266-018-0544-4","article-title":"Deprescribing benzodiazepines in older patients: impact of interventions targeting physicians, pharmacists, and patients","volume":"35","author":"Ng","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.therap.2021.09.001_bib0415","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1370\/afm.2094","article-title":"Swimming against the tide: primary care physicians\u2019 views on deprescribing in everyday practice","volume":"15","author":"Wallis","year":"2017","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.therap.2021.09.001_bib0420","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"147","author":"Von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.therap.2021.09.001_bib0425","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.medmal.2015.09.005","article-title":"Design of a national and regional survey among French general practitioners and method of the first wave of survey dedicated to vaccination","volume":"45","author":"Le Mar\u00e9chal","year":"2015","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.therap.2021.09.001_bib0430","doi-asserted-by":"crossref","first-page":"E270","DOI":"10.3399\/bjgp19X701801","article-title":"GPs\u2019 management of polypharmacy and therapeutic dilemma in patients with multimorbidity: A cross-sectional survey of GPS in France","volume":"69","author":"Carrier","year":"2019","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.therap.2021.09.001_bib0435","series-title":"Polym\u00e9dication et pathologies chroniques multiples: opinions et pratiques des m\u00e9decins g\u00e9n\u00e9ralistes. DREES, \u00e9tudes et r\u00e9sultats","author":"Carrier","year":"2017"},{"key":"10.1016\/j.therap.2021.09.001_bib0440","series-title":"Redresser la non-r\u00e9ponse totale dans les enqu\u00eates aupr\u00e8s des entreprises: les pi\u00e8ges \u00e0 \u00e9viter. Illustration avec l\u2019enqu\u00eate innovation. Insee - Actes des journ\u00e9es m\u00e9thodologie statistiques","author":"Brion","year":"2005"},{"key":"10.1016\/j.therap.2021.09.001_bib0445","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40258-013-0014-4","article-title":"Multilevel analysis of the influence of patients\u2019 and general practitioners\u2019 characteristics on patented versus multiple-sourced statin prescribing in France","volume":"11","author":"Pichetti","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.therap.2021.09.001_bib0450","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/intqhc\/mzx074","article-title":"Organizational and managerial factors associated with clinical practice guideline adherence: A simulation-based study in 36 French hospital wards","volume":"29","author":"Saillour-Gl\u00e9nisson","year":"2017","journal-title":"Int J Qual Heal Care"},{"key":"10.1016\/j.therap.2021.09.001_bib0455","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/1077558710397761","article-title":"General practitioners and clinical practice guidelines: A reexamination","volume":"68","author":"Clerc","year":"2011","journal-title":"Med Care Res Rev"},{"key":"10.1016\/j.therap.2021.09.001_bib0460","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1177\/1049732316687732","article-title":"Negotiating \u201cUnmeasurable Harm and Benefit\u201d: Perspectives of General Practitioners and Consultant Pharmacists on Deprescribing in the Primary Care Setting","volume":"27","author":"Anderson","year":"2017","journal-title":"Qual Health Res"},{"key":"10.1016\/j.therap.2021.09.001_bib0465","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.2009.155","article-title":"The feminization of medicine and population health","volume":"301","author":"Phillips","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2021.09.001_bib0470","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MLR.0000000000000480","article-title":"A comprehensive assessment of family physician gender and quality of care","volume":"54","author":"Dahrouge","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.therap.2021.09.001_bib0475","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.publhealth.25.101802.123134","article-title":"Physician gender and patient-centered communication: a critical review of empirical research","volume":"25","author":"Roter","year":"2004","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.therap.2021.09.001_bib0480","series-title":"Ressources en sant\u00e9: m\u00e9decins par \u00e2ge et sexe","author":"OECD","year":"2019"},{"key":"10.1016\/j.therap.2021.09.001_bib0485","series-title":"Rapport sur la surveillance et la promotion du bon usage du m\u00e9dicament en France","author":"B\u00e9gaud","year":"2013"},{"key":"10.1016\/j.therap.2021.09.001_bib0490","first-page":"192","article-title":"Prescribe, but also know how to \u201cdeprescribe\u201d","volume":"22","author":"Montastruc","year":"2013","journal-title":"Prescrire Int"},{"key":"10.1016\/j.therap.2021.09.001_bib0495","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1586\/ecp.11.14","article-title":"Combating inappropriate use of medicines","volume":"4","author":"Holloway","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.therap.2021.09.001_bib0500","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cger.2017.01.004","article-title":"The role of patient preferences in deprescribing","volume":"33","author":"Holmes","year":"2017","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.therap.2021.09.001_bib0505","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/j.1360-0443.2012.03975.x","article-title":"Correlates of benzodiazepine dependence in the Netherlands Study of depression and anxiety","volume":"107","author":"Manthey","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.therap.2021.09.001_bib0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/sleep\/zsx147","article-title":"Eight-year follow-up of hypnotic delivery by adults aged 50 and older from an insurance database","volume":"40","author":"Verger","year":"2017","journal-title":"Sleep"},{"key":"10.1016\/j.therap.2021.09.001_bib0515","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101014","article-title":"Combatting the misuse of benzodiazepines and related Z drugs in French general practice: A clinical review","volume":"4","author":"Gentile","year":"2020","journal-title":"BJGP Open"},{"key":"10.1016\/j.therap.2021.09.001_bib0520","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/eb-2012-100930","article-title":"Deciding when to stop: Towards evidence-based deprescribing of drugs in older populations","volume":"18","author":"Scott","year":"2013","journal-title":"Evid Based Med"},{"key":"10.1016\/j.therap.2021.09.001_bib0525","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bcp.12386","article-title":"Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process","volume":"78","author":"Reeve","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.therap.2021.09.001_bib0530","first-page":"436","article-title":"Deprescribing: A simple method for reducing polypharmacy","volume":"66","author":"McGrath","year":"2017","journal-title":"J Fam Pract"},{"key":"10.1016\/j.therap.2021.09.001_bib0535","article-title":"Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users","volume":"3","author":"Baandrup","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.therap.2021.09.001_bib0540","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00228-017-2257-8","article-title":"A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people","volume":"73","author":"Reeve","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2021.09.001_bib0545","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.3399\/bjgp17X691073","article-title":"Beliefs about prescribed medication among older patients with polypharmacy: A mixed methods study in primary care","volume":"67","author":"Clyne","year":"2017","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.therap.2021.09.001_bib0550","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","article-title":"Patient barriers to and enablers of deprescribing: A systematic review","volume":"30","author":"Reeve","year":"2013","journal-title":"Drugs Aging"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721001797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721001797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:55:05Z","timestamp":1758567305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595721001797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0040595721001797"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2021.09.001","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"General practitioners\u2019 compliance with benzodiazepine discontinuation guidelines in patients treated with long-term lorazepam: A case-vignette cross-sectional survey","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2021.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}